טוען...
Finding new lanes: Chimeric antigen receptor (CAR) T‐cells for myeloid leukemia
BACKGROUND: Myeloid leukemia represents a heterogeneous group of cancers of blood and bone marrow which arise from clonal expansion of hematopoietic myeloid lineage cells. Acute myeloid leukemia (AML) has traditionally been treated with multi‐agent chemotherapy, but conventional therapies have not i...
שמור ב:
| הוצא לאור ב: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941581/ https://ncbi.nlm.nih.gov/pubmed/32671999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1222 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|